Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 177

1.

Management of severe acute pancreatitis.

Hines OJ, Pandol SJ.

BMJ. 2019 Dec 2;367:l6227. doi: 10.1136/bmj.l6227. Review.

PMID:
31791953
2.

Trypsin activity governs increased susceptibility to pancreatitis in mice expressing human PRSS1R122H.

Gui F, Zhang Y, Wan J, Zhan X, Yao Y, Li Y, Haddock AN, Shi J, Guo J, Chen J, Zhu X, Edenfield BH, Zhuang L, Hu C, Wang Y, Mukhopadhyay D, Radisky ES, Zhang L, Lugea A, Pandol SJ, Bi Y, Ji B.

J Clin Invest. 2019 Nov 18. pii: 130172. doi: 10.1172/JCI130172. [Epub ahead of print]

3.

Simvastatin induces autophagic flux to restore cerulein-impaired phagosome-lysosome fusion in acute pancreatitis.

Piplani H, Marek-Iannucci S, Sin J, Hou J, Takahashi T, Sharma A, de Freitas Germano J, Waldron RT, Saadaeijahromi H, Song Y, Gulla A, Wu B, Lugea A, Andres AM, Gaisano HY, Gottlieb RA, Pandol SJ.

Biochim Biophys Acta Mol Basis Dis. 2019 Nov 1;1865(11):165530. doi: 10.1016/j.bbadis.2019.08.006. Epub 2019 Aug 6.

PMID:
31398467
4.

New-Onset Diabetes Mellitus After Chronic Pancreatitis Diagnosis: A Systematic Review and Meta-analysis.

Zhu X, Liu D, Wei Q, Lin H, Zhi M, Chen Y, Qi L, Waldron RT, Lugea A, Pandol SJ, Li L.

Pancreas. 2019 Aug;48(7):868-875. doi: 10.1097/MPA.0000000000001359.

PMID:
31268977
5.

Do changes in health reveal the possibility of undiagnosed pancreatic cancer? Development of a risk-prediction model based on healthcare claims data.

Baecker A, Kim S, Risch HA, Nuckols TK, Wu BU, Hendifar AE, Pandol SJ, Pisegna JR, Jeon CY.

PLoS One. 2019 Jun 25;14(6):e0218580. doi: 10.1371/journal.pone.0218580. eCollection 2019.

6.

Genetic Risk Score in Diabetes Associated With Chronic Pancreatitis Versus Type 2 Diabetes Mellitus.

Goodarzi MO, Nagpal T, Greer P, Cui J, Chen YI, Guo X, Pankow JS, Rotter JI, Alkaade S, Amann ST, Baillie J, Banks PA, Brand RE, Conwell DL, Cote GA, Forsmark CE, Gardner TB, Gelrud A, Guda N, LaRusch J, Lewis MD, Money ME, Muniraj T, Papachristou GI, Romagnuolo J, Sandhu BS, Sherman S, Singh VK, Wilcox CM, Pandol SJ, Park WG, Andersen DK, Bellin MD, Hart PA, Yadav D, Whitcomb DC; Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC).

Clin Transl Gastroenterol. 2019 Jul;10(7):e00057. doi: 10.14309/ctg.0000000000000057.

7.

Incidence of New Onset Diabetes Mellitus Secondary to Acute Pancreatitis: A Systematic Review and Meta-Analysis.

Zhi M, Zhu X, Lugea A, Waldron RT, Pandol SJ, Li L.

Front Physiol. 2019 May 31;10:637. doi: 10.3389/fphys.2019.00637. eCollection 2019.

8.

Antidiabetic Medications and Mortality Risk in Individuals With Pancreatic Cancer-Related Diabetes and Postpancreatitis Diabetes: A Nationwide Cohort Study.

Cho J, Scragg R, Pandol SJ, Goodarzi MO, Petrov MS.

Diabetes Care. 2019 Sep;42(9):1675-1683. doi: 10.2337/dc19-0145. Epub 2019 Jun 21.

PMID:
31227582
9.

Animal Models: Challenges and Opportunities to Determine Optimal Experimental Models of Pancreatitis and Pancreatic Cancer.

Saloman JL, Albers KM, Cruz-Monserrate Z, Davis BM, Edderkaoui M, Eibl G, Epouhe AY, Gedeon JY, Gorelick FS, Grippo PJ, Groblewski GE, Husain SZ, Lai KKY, Pandol SJ, Uc A, Wen L, Whitcomb DC.

Pancreas. 2019 Jul;48(6):759-779. doi: 10.1097/MPA.0000000000001335.

PMID:
31206467
10.

Acute Pancreatitis Task Force on Quality: Development of Quality Indicators for Acute Pancreatitis Management.

Vivian E, Cler L, Conwell D, Coté GA, Dickerman R, Freeman M, Gardner TB, Hawes RH, Kedia P, Krishnamoorthi R, Oduor H, Pandol SJ, Papachristou GI, Ross A, Sethi A, Varadarajulu S, Vege SS, Wassef W, Wilcox CM, Whitcomb DC, Wu BU, Yadav D, Ellison A, Habash S, Rastegari S, Reddy R, Yen T, Brooks MR, Tarnasky P.

Am J Gastroenterol. 2019 Aug;114(8):1322-1342. doi: 10.14309/ajg.0000000000000264.

PMID:
31205135
11.

Differences in Pancreatic Cancer Incidence Rates and Temporal Trends Across Asian Subpopulations in California (1988-2015).

Liu L, Zhang J, Deapen D, Stern MC, Sipin A, Pandol SJ, Setiawan VW.

Pancreas. 2019 Aug;48(7):931-933. doi: 10.1097/MPA.0000000000001337.

PMID:
31180980
12.

Protective effects of urocortin 2 against caerulein-induced acute pancreatitis.

Yuan J, Hasdemir B, Tan T, Chheda C, Rivier J, Pandol SJ, Bhargava A.

PLoS One. 2019 May 17;14(5):e0217065. doi: 10.1371/journal.pone.0217065. eCollection 2019.

13.

Magnetic resonance imaging as a non-invasive method for the assessment of pancreatic fibrosis (MINIMAP): a comprehensive study design from the consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer.

Tirkes T, Yadav D, Conwell DL, Territo PR, Zhao X, Venkatesh SK, Kolipaka A, Li L, Pisegna JR, Pandol SJ, Park WG, Topazian M, Serrano J, Fogel EL; Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer.

Abdom Radiol (NY). 2019 Aug;44(8):2809-2821. doi: 10.1007/s00261-019-02049-5.

PMID:
31089778
14.

Interethnic differences in pancreatic cancer incidence and risk factors: The Multiethnic Cohort.

Huang BZ, Stram DO, Le Marchand L, Haiman CA, Wilkens LR, Pandol SJ, Zhang ZF, Monroe KR, Setiawan VW.

Cancer Med. 2019 Jul;8(7):3592-3603. doi: 10.1002/cam4.2209. Epub 2019 May 8.

15.

The Orai Ca2+ channel inhibitor CM4620 targets both parenchymal and immune cells to reduce inflammation in experimental acute pancreatitis.

Waldron RT, Chen Y, Pham H, Go A, Su HY, Hu C, Wen L, Husain SZ, Sugar CA, Roos J, Ramos S, Lugea A, Dunn M, Stauderman K, Pandol SJ.

J Physiol. 2019 Jun;597(12):3085-3105. doi: 10.1113/JP277856. Epub 2019 May 22.

PMID:
31050811
16.

NOD-like receptor C4 Inflammasome Regulates the Growth of Colon Cancer Liver Metastasis in NAFLD.

Ohashi K, Wang Z, Yang YM, Billet S, Tu W, Pimienta M, Cassel SL, Pandol SJ, Lu SC, Sutterwala FS, Bhowmick N, Seki E.

Hepatology. 2019 Nov;70(5):1582-1599. doi: 10.1002/hep.30693. Epub 2019 May 23.

PMID:
31044438
17.

Recent Insights Into the Pathogenic Mechanism of Pancreatitis: Role of Acinar Cell Organelle Disorders.

Gukovskaya AS, Gorelick FS, Groblewski GE, Mareninova OA, Lugea A, Antonucci L, Waldron RT, Habtezion A, Karin M, Pandol SJ, Gukovsky I.

Pancreas. 2019 Apr;48(4):459-470. doi: 10.1097/MPA.0000000000001298. Review.

PMID:
30973461
18.

MSP-RON Signaling Is Activated in the Transition From Pancreatic Intraepithelial Neoplasia (PanIN) to Pancreatic Ductal Adenocarcinoma (PDAC).

Li C, Morvaridi S, Lam G, Chheda C, Kamata Y, Katsumata M, Edderkaoui M, Yuan X, Nissen N, Pandol SJ, Wang Q.

Front Physiol. 2019 Feb 26;10:147. doi: 10.3389/fphys.2019.00147. eCollection 2019.

19.

STING signalling protects against chronic pancreatitis by modulating Th17 response.

Zhao Q, Manohar M, Wei Y, Pandol SJ, Habtezion A.

Gut. 2019 Oct;68(10):1827-1837. doi: 10.1136/gutjnl-2018-317098. Epub 2019 Jan 31.

PMID:
30705050
20.

Acute Pancreatitis: A Multifaceted Set of Organelle and Cellular Interactions.

Habtezion A, Gukovskaya AS, Pandol SJ.

Gastroenterology. 2019 May;156(7):1941-1950. doi: 10.1053/j.gastro.2018.11.082. Epub 2019 Jan 18. Review.

21.

Spatial Mapping of Myeloid Cells and Macrophages by Multiplexed Tissue Staining.

Saylor J, Ma Z, Goodridge HS, Huang F, Cress AE, Pandol SJ, Shiao SL, Vidal AC, Wu L, Nickols NG, Gertych A, Knudsen BS.

Front Immunol. 2018 Dec 14;9:2925. doi: 10.3389/fimmu.2018.02925. eCollection 2018.

22.

Chlorophyllin Modulates Gut Microbiota and Inhibits Intestinal Inflammation to Ameliorate Hepatic Fibrosis in Mice.

Zheng H, You Y, Hua M, Wu P, Liu Y, Chen Z, Zhang L, Wei H, Li Y, Luo M, Zeng Y, Liu Y, Luo DX, Zhang J, Feng M, Hu R, Pandol SJ, Han YP.

Front Physiol. 2018 Dec 4;9:1671. doi: 10.3389/fphys.2018.01671. eCollection 2018.

23.

Frequency and risk factors for liver disease following pancreatitis: A population-based cohort study.

Chand SK, Pendharkar SA, Bharmal SH, Bartlett AS, Pandol SJ, Petrov MS.

Dig Liver Dis. 2019 Apr;51(4):551-558. doi: 10.1016/j.dld.2018.11.001. Epub 2018 Nov 16.

24.

A Prospective Study to Establish a New-Onset Diabetes Cohort: From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer.

Maitra A, Sharma A, Brand RE, Van Den Eeden SK, Fisher WE, Hart PA, Hughes SJ, Mather KJ, Pandol SJ, Park WG, Feng Z, Serrano J, Rinaudo JAS, Srivastava S, Chari ST; Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC).

Pancreas. 2018 Nov/Dec;47(10):1244-1248. doi: 10.1097/MPA.0000000000001169.

25.

PROspective Evaluation of Chronic Pancreatitis for EpidEmiologic and Translational StuDies: Rationale and Study Design for PROCEED From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer.

Yadav D, Park WG, Fogel EL, Li L, Chari ST, Feng Z, Fisher WE, Forsmark CE, Jeon CY, Habtezion A, Hart PA, Hughes SJ, Othman MO, Rinaudo JAS, Pandol SJ, Tirkes T, Serrano J, Srivastava S, Van Den Eeden SK, Whitcomb DC, Topazian M, Conwell DL; Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC).

Pancreas. 2018 Nov/Dec;47(10):1229-1238. doi: 10.1097/MPA.0000000000001170.

26.

Standard Operating Procedures for Biospecimen Collection, Processing, and Storage: From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer.

Fisher WE, Cruz-Monserrate Z, McElhany AL, Lesinski GB, Hart PA, Ghosh R, Van Buren G, Fishman DS, Rinaudo JAS, Serrano J, Srivastava S, Mace T, Topazian M, Feng Z, Yadav D, Pandol SJ, Hughes SJ, Liu RY, Lu E, Orr R, Whitcomb DC, Abouhamze AS, Steen H, Sellers ZM, Troendle DM, Uc A, Lowe ME, Conwell DL; Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC).

Pancreas. 2018 Nov/Dec;47(10):1213-1221. doi: 10.1097/MPA.0000000000001171.

27.

Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer: From Concept to Reality.

Serrano J, Andersen DK, Forsmark CE, Pandol SJ, Feng Z, Srivastava S, Rinaudo JAS; Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC).

Pancreas. 2018 Nov/Dec;47(10):1208-1212. doi: 10.1097/MPA.0000000000001167.

28.

Accelerating the Drug Delivery Pipeline for Acute and Chronic Pancreatitis: Summary of the Working Group on Drug Development and Trials in Chronic Pancreatitis at the National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Forsmark CE, Andersen DK, Farrar JT, Golden M, Habtezion A, Husain SZ, Li L, Mayerle J, Pandol SJ, Uc A, Zhu Z, Yadav D.

Pancreas. 2018 Nov/Dec;47(10):1200-1207. doi: 10.1097/MPA.0000000000001174.

29.

Accelerating the Drug Delivery Pipeline for Acute and Chronic Pancreatitis: Summary of the Working Group on Drug Development and Trials in Recurrent Acute Pancreatitis at the National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Lowe ME, Goodman MT, Coté GA, Glesby MJ, Haupt M, Schork NJ, Singh VK, Andersen DK, Pandol SJ, Uc A, Whitcomb DC.

Pancreas. 2018 Nov/Dec;47(10):1193-1199. doi: 10.1097/MPA.0000000000001164.

30.

Accelerating the Drug Delivery Pipeline for Acute and Chronic Pancreatitis: Summary of the Working Group on Drug Development and Trials in Acute Pancreatitis at the National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Abu-El-Haija M, Gukovskaya AS, Andersen DK, Gardner TB, Hegyi P, Pandol SJ, Papachristou GI, Saluja AK, Singh VK, Uc A, Wu BU.

Pancreas. 2018 Nov/Dec;47(10):1185-1192. doi: 10.1097/MPA.0000000000001175.

31.

Accelerating the Drug Delivery Pipeline for Acute and Chronic Pancreatitis-Knowledge Gaps and Research Opportunities: Overview Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Uc A, Andersen DK, Borowitz D, Glesby MJ, Mayerle J, Sutton R, Pandol SJ.

Pancreas. 2018 Nov/Dec;47(10):1180-1184. doi: 10.1097/MPA.0000000000001176.

32.

The Agenda for Accelerating Pancreatic Research.

Andersen DK, Forsmark CE, Pandol SJ.

Pancreas. 2018 Nov/Dec;47(10):1177-1179. doi: 10.1097/MPA.0000000000001163. No abstract available.

33.

Proteomic Identification of Novel Plasma Biomarkers and Pathobiologic Pathways in Alcoholic Acute Pancreatitis.

Waldron RT, Lugea A, Gulla A, Pandol SJ.

Front Physiol. 2018 Aug 30;9:1215. doi: 10.3389/fphys.2018.01215. eCollection 2018.

34.

An Inhibitor of GSK3B and HDACs Kills Pancreatic Cancer Cells and Slows Pancreatic Tumor Growth and Metastasis in Mice.

Edderkaoui M, Chheda C, Soufi B, Zayou F, Hu RW, Ramanujan VK, Pan X, Boros LG, Tajbakhsh J, Madhav A, Bhowmick NA, Wang Q, Lewis M, Tuli R, Habtezion A, Murali R, Pandol SJ.

Gastroenterology. 2018 Dec;155(6):1985-1998.e5. doi: 10.1053/j.gastro.2018.08.028. Epub 2018 Aug 23.

35.

Disease Course Differences in Acute Pancreatitis Based on Etiology Using the Pancreatitis Activity Scoring System.

Lew D, Wu BU, Pandol SJ, Sugar CA, Senturk D, Afghani E.

Pancreas. 2018 Aug;47(7):e40-e41. doi: 10.1097/MPA.0000000000001091. No abstract available.

36.

Ethanol Induced Disordering of Pancreatic Acinar Cell Endoplasmic Reticulum: An ER Stress/Defective Unfolded Protein Response Model.

Waldron RT, Su HY, Piplani H, Capri J, Cohn W, Whitelegge JP, Faull KF, Sakkiah S, Abrol R, Yang W, Zhou B, Freeman MR, Pandol SJ, Lugea A.

Cell Mol Gastroenterol Hepatol. 2018 Jan 6;5(4):479-497. doi: 10.1016/j.jcmgh.2018.01.001. eCollection 2018.

37.

Pancreatic Cancer Following Incident Diabetes in African Americans and Latinos: The Multiethnic Cohort.

Setiawan VW, Stram DO, Porcel J, Chari ST, Maskarinec G, Le Marchand L, Wilkens LR, Haiman CA, Pandol SJ, Monroe KR.

J Natl Cancer Inst. 2019 Jan 1;111(1):27-33. doi: 10.1093/jnci/djy090.

38.

Advances in Pancreatic Cancer, Intraductal Papillary Mucinous Neoplasms, and Pancreatitis.

Vege SS, Pandol SJ.

Gastroenterology. 2018 Sep;155(3):581-583. doi: 10.1053/j.gastro.2018.05.019. Epub 2018 Aug 2. No abstract available.

39.

The Interface of Pancreatic Cancer With Diabetes, Obesity, and Inflammation: Research Gaps and Opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Abbruzzese JL, Andersen DK, Borrebaeck CAK, Chari ST, Costello E, Cruz-Monserrate Z, Eibl G, Engleman EG, Fisher WE, Habtezion A, Kim SK, Korc M, Logsdon C, Lyssiotis CA, Pandol SJ, Rustgi A, Wolfe BM, Zheng L, Powers AC.

Pancreas. 2018 May/Jun;47(5):516-525. doi: 10.1097/MPA.0000000000001037.

40.

Differentiation Therapy Targeting the β-Catenin/CBP Interaction in Pancreatic Cancer.

Manegold P, Lai KKY, Wu Y, Teo JL, Lenz HJ, Genyk YS, Pandol SJ, Wu K, Lin DP, Chen Y, Nguyen C, Zhao Y, Kahn M.

Cancers (Basel). 2018 Mar 29;10(4). pii: E95. doi: 10.3390/cancers10040095.

41.

STING Signaling Promotes Inflammation in Experimental Acute Pancreatitis.

Zhao Q, Wei Y, Pandol SJ, Li L, Habtezion A.

Gastroenterology. 2018 May;154(6):1822-1835.e2. doi: 10.1053/j.gastro.2018.01.065. Epub 2018 Feb 6.

42.

Novel Small Molecule Inhibitors of Protein Kinase D Suppress NF-kappaB Activation and Attenuate the Severity of Rat Cerulein Pancreatitis.

Yuan J, Tan T, Geng M, Tan G, Chheda C, Pandol SJ.

Front Physiol. 2017 Dec 7;8:1014. doi: 10.3389/fphys.2017.01014. eCollection 2017.

43.

Alternation of Gut Microbiota in Patients with Pulmonary Tuberculosis.

Luo M, Liu Y, Wu P, Luo DX, Sun Q, Zheng H, Hu R, Pandol SJ, Li QF, Han YP, Zeng Y.

Front Physiol. 2017 Nov 17;8:822. doi: 10.3389/fphys.2017.00822. eCollection 2017.

44.

Tobacco and alcohol as risk factors for pancreatic cancer.

Korc M, Jeon CY, Edderkaoui M, Pandol SJ, Petrov MS; Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC).

Best Pract Res Clin Gastroenterol. 2017 Oct;31(5):529-536. doi: 10.1016/j.bpg.2017.09.001. Epub 2017 Sep 6. Review.

45.

The Differential Role of Human Cationic Trypsinogen (PRSS1) p.R122H Mutation in Hereditary and Nonhereditary Chronic Pancreatitis: A Systematic Review and Meta-Analysis.

Hu C, Wen L, Deng L, Zhang C, Lugea A, Su HY, Waldron RT, Pandol SJ, Xia Q.

Gastroenterol Res Pract. 2017;2017:9505460. doi: 10.1155/2017/9505460. Epub 2017 Oct 8. Review.

46.

S-adenosylmethionine and methylthioadenosine inhibit cancer metastasis by targeting microRNA 34a/b-methionine adenosyltransferase 2A/2B axis.

Tomasi ML, Cossu C, Spissu Y, Floris A, Ryoo M, Iglesias-Ara A, Wang Q, Pandol SJ, Bhowmick NA, Seki E, Posadas EM, Lu SC.

Oncotarget. 2017 Aug 12;8(45):78851-78869. doi: 10.18632/oncotarget.20234. eCollection 2017 Oct 3.

47.

Relationship between circulating levels of pancreatic proteolytic enzymes and pancreatic hormones.

Bharmal SH, Pendharkar SA, Singh RG, Goodarzi MO, Pandol SJ, Petrov MS.

Pancreatology. 2017 Nov - Dec;17(6):876-883. doi: 10.1016/j.pan.2017.09.007. Epub 2017 Sep 20.

48.

Human Pancreatic Acinar Cells: Proteomic Characterization, Physiologic Responses, and Organellar Disorders in ex Vivo Pancreatitis.

Lugea A, Waldron RT, Mareninova OA, Shalbueva N, Deng N, Su HY, Thomas DD, Jones EK, Messenger SW, Yang J, Hu C, Gukovsky I, Liu Z, Groblewski GE, Gukovskaya AS, Gorelick FS, Pandol SJ.

Am J Pathol. 2017 Dec;187(12):2726-2743. doi: 10.1016/j.ajpath.2017.08.017. Epub 2017 Sep 19.

49.

Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer.

Eibl G, Cruz-Monserrate Z, Korc M, Petrov MS, Goodarzi MO, Fisher WE, Habtezion A, Lugea A, Pandol SJ, Hart PA, Andersen DK; Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer.

J Acad Nutr Diet. 2018 Apr;118(4):555-567. doi: 10.1016/j.jand.2017.07.005. Epub 2017 Sep 12. Review.

50.

Incidence of pancreatic cancer is dramatically increased by a high fat, high calorie diet in KrasG12D mice.

Chang HH, Moro A, Takakura K, Su HY, Mo A, Nakanishi M, Waldron RT, French SW, Dawson DW, Hines OJ, Li G, Go VLW, Sinnett-Smith J, Pandol SJ, Lugea A, Gukovskaya AS, Duff MO, Rosenberg DW, Rozengurt E, Eibl G.

PLoS One. 2017 Sep 8;12(9):e0184455. doi: 10.1371/journal.pone.0184455. eCollection 2017.

Supplemental Content

Loading ...
Support Center